ADVERTISEMENTREMOVE AD
×
×

Serum Institute Of India

FAQ | India's First Home-Grown HPV Vaccine Launched: How Much Will It Cost?

Man Sues SII, Bill Gates Over Death of Daughter Allegedly Due to Covishield

ADVERTISEMENTREMOVE AD

FAQ | India’s First HPV Vaccine for Cervical Cancer: Why Do We Need It?

SII Chief Adar Poonawalla Hopes for a Global Treaty To Gear Up for Next Pandemic

Immunisation Panel Approves Use Of SII's Covovax For 12-17 Age Group: Report

Novovax's COVID-19 Vaccine Gets Emergency Use Nod From DCGI for Kids Aged 12-17

SII's Covovax Receives Emergency Use Approval for Adults, Children Over 12

Covovax Becomes 9th Vaccine To Receive WHO's Emergency Approval

SII to Launch COVID-19 Vaccine for Children in 6 Months: Adar Poonawalla

With Over 1.25 Billion Jabs in India, SII Seeks Full Approval for Covishield

Covishield Booster Dose: Expert Panel Seeks Local Trial Data for Approval

Serum Institute Seeks Approval for Covishield as Booster Dose From DGCI

Man Sues SII, Bill Gates Over Death of Daughter Allegedly Due to Covishield

FAQ | India’s First HPV Vaccine for Cervical Cancer: Why Do We Need It?

Immunisation Panel Approves Use Of SII's Covovax For 12-17 Age Group: Report

Novovax's COVID-19 Vaccine Gets Emergency Use Nod From DCGI for Kids Aged 12-17

With Over 1.25 Billion Jabs in India, SII Seeks Full Approval for Covishield

Covovax Becomes 9th Vaccine To Receive WHO's Emergency Approval

Covishield Booster Dose: Expert Panel Seeks Local Trial Data for Approval

Serum Institute Seeks Approval for Covishield as Booster Dose From DGCI